XML 26 R33.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Basis of Presentation (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2013
Basis of Presentation |
Schedule of details of the Company's subsidiaries |
Name |  | Date of incorporation or establishment |  | Place of incorporation (or establishment) /operation |  | Percentage of ownership as of December 31, 2013 |  | Percentage of ownership as of December 31, 2012 |  | Principal activity
Sinovac Biotech (Hong Kong) Ltd (“Sinovac Hong Kong”) |  | October 2008 |  | Hong Kong |  | 100% |  | 100% |  | Investment holding company
Sinovac Biotech Co., Ltd. (“Sinovac Beijing”) (note 11) |  | April 2001 |  | PRC |  | 73.09% |  | 73.09% |  | Research and development, production and sales of vaccine products
Tangshan Yian Biological Engineering Co., Ltd (“Tangshan Yian”) |  | February1993 |  | PRC |  | 100% |  | 100% |  | Research and development, production and sales of vaccine products
Sinovac Biological Technology Co., Ltd. (“Sinovac R&D”) |  | May2009 |  | PRC |  | 100% |  | 100% |  | Research and development of vaccine products
Sinovac (Dalian) Vaccine Technology Co., Ltd. (“Sinovac Dalian”) (note 11) |  | January2010 |  | PRC |  | 55% |  | 55% |  | Research and development, production and sales of vaccine products

X
- Definition Tabular disclosure of investments in and advances to affiliates. Does not include the tabular disclosure of the disaggregation of investments in and advances to affiliates across legal entities. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 320 -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14) -URI http://asc.fasb.org/extlink&oid=6955306&loc=d3e611322-123010 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 14 -Article 12 + Details
Name: | us-gaap_InvestmentsInAndAdvancesToAffiliatesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration